Insulet
PODD
₹21,856
Share price
1.00%
Change (1 day)
49.18%
Change (1 year)
Categories
Insulet Corporation is an American company that develops and sells medical devices used for the administration of insulin.
Insulet (PODD) - Net assets
Net assets on the balance sheet as of December 2024 : ₹104.25 Billion
According to Insulet's latest financial reports the company has ₹104.25 Billion in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
Insulet - Net assets on balance sheet (from 2005 to 2024)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2024-12-31 | $₹103.93 B | 70.4% |
| 2023-12-31 | $₹60.99 B | 54.73% |
| 2022-12-31 | $₹39.42 B | -4.79% |
| 2021-12-31 | $₹41.40 B | -6.2% |
| 2020-12-31 | $₹44.14 B | 715.59% |
| 2019-12-31 | $₹5.41 B | -63.5% |
| 2018-12-31 | $₹14.83 B | 46.53% |
| 2017-12-31 | $₹10.12 B | 135.86% |
| 2016-12-31 | $₹4.29 B | 89.64% |
| 2015-12-31 | $₹2.26 B | -57.41% |
| 2014-12-31 | $₹5.31 B | -30.98% |
| 2013-12-31 | $₹7.69 B | 218.24% |
| 2012-12-31 | $₹2.41 B | -44.74% |
| 2011-12-31 | $₹4.37 B | 47.47% |
| 2010-12-31 | $₹2.96 B | 21.01% |
| 2009-12-31 | $₹2.45 B | 81.55% |
| 2008-12-31 | $₹1.35 B | -62.7% |
| 2007-12-31 | $₹3.62 B | -180.35% |
| 2006-12-31 | $-₹4.51 Billion | 51.55% |
| 2005-12-31 | $-₹2.98 Billion | 54.29% |
| 2004-12-31 | $-₹1.93 Billion | 38.13% |
| 2003-12-31 | $-₹1.4 Billion | 56.01% |
| 2002-12-31 | $-₹0.9 Billion |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 | ₹169.10 B | 62.20% | 🇺🇸 USA |
 | ₹22.63 B | -78.29% | 🇺🇸 USA |
 | ₹180.92 B | 73.54% | 🇺🇸 USA |
 | ₹6.151 T | 5,800.46% | 🇺🇸 USA |
 | ₹4.121 T | 3,853.53% | 🇺🇸 USA |
 | ₹4.269 T | 3,995.00% | 🇮🇪 Ireland |
 | ₹1.228 T | 1,077.91% | 🇺🇸 USA |